DIT vs REGN · P/E 173, $79.1M cap vs P/E 14, rev $14.34B
AMCON Distributing Company (DIT) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
AMCON Distributing Company (DIT) is a food distribution company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
DIT does not have a complete income-statement cache yet.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DIT currently screens at market cap $79.1M and trailing P/E 172.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DIT and REGN stock pages for the full models.
Not investment advice.